Lambrecht M., Van Herck H., De Keyzer F., Vandecaveye V., Slagmolen P., Suetens P., Hermans R., Nuyts S., ''Redefining the target early during treatment. Can we visualize regional differences within the target volume using sequential diffusion weighted MRI?'', Radiotherapy and oncology, vol. 110, no. 2, pp. 329-334, February 2014.status: publishe
To evaluate changes in apparent diffusion coefficients (ADC) as measured by magnetic resonance imagi...
Background: A surrogate marker for treatment response that can be ob-served earlier than comparison ...
With the association of concurrent chemotherapy, the widespread implementation of altered fractionat...
PURPOSE: In head and neck cancer, diffusion weighted MRI (DWI) can predict response early during tre...
The use of anatomical imaging in clinical oncology practice traditionally relies on comparison of pa...
PURPOSE:MRI biomarkers of tumor response to treatment are typically obtained from parameters derived...
Objective To evaluate changes in apparent diffusion coefficients (ADC) as measured by magnetic reson...
The efficiency of an oncological treatment regimen is often assessed by morphological criteria such ...
An imaging biomarker that would provide for an early quantitative metric of clinical treatment respo...
PURPOSE: MRI biomarkers of tumor response to treatment are typically obtained from parameters derive...
Introduction: Inter-observer variability (IOV) in target volume delineation is a source of error in ...
Background and purpose: Diffusion weighted (DW) MRI may facilitate target volume delineation for hea...
In radiotherapy treatment planning, tumor delineation based on diffusion-weighted imaging (DWI) by m...
PURPOSE: To evaluate the use of diffusion-weighted magnetic resonance imaging (DW-MRI) for nodal sta...
Background and purpose: Dose escalation has improved cancer outcomes for patients with localized pro...
To evaluate changes in apparent diffusion coefficients (ADC) as measured by magnetic resonance imagi...
Background: A surrogate marker for treatment response that can be ob-served earlier than comparison ...
With the association of concurrent chemotherapy, the widespread implementation of altered fractionat...
PURPOSE: In head and neck cancer, diffusion weighted MRI (DWI) can predict response early during tre...
The use of anatomical imaging in clinical oncology practice traditionally relies on comparison of pa...
PURPOSE:MRI biomarkers of tumor response to treatment are typically obtained from parameters derived...
Objective To evaluate changes in apparent diffusion coefficients (ADC) as measured by magnetic reson...
The efficiency of an oncological treatment regimen is often assessed by morphological criteria such ...
An imaging biomarker that would provide for an early quantitative metric of clinical treatment respo...
PURPOSE: MRI biomarkers of tumor response to treatment are typically obtained from parameters derive...
Introduction: Inter-observer variability (IOV) in target volume delineation is a source of error in ...
Background and purpose: Diffusion weighted (DW) MRI may facilitate target volume delineation for hea...
In radiotherapy treatment planning, tumor delineation based on diffusion-weighted imaging (DWI) by m...
PURPOSE: To evaluate the use of diffusion-weighted magnetic resonance imaging (DW-MRI) for nodal sta...
Background and purpose: Dose escalation has improved cancer outcomes for patients with localized pro...
To evaluate changes in apparent diffusion coefficients (ADC) as measured by magnetic resonance imagi...
Background: A surrogate marker for treatment response that can be ob-served earlier than comparison ...
With the association of concurrent chemotherapy, the widespread implementation of altered fractionat...